Structural and functional analysis of cooperativity in a potent human antibody cocktail against Ebola virus
Pavlo Gilchuk(AstraZeneca (Japan)), James E. Crowe(Vanderbilt University Medical Center), Bronwyn M. Gunn(Washington State University), Robert H. Carnahan(Vanderbilt University Medical Center), Alexander Bukreyev(Galveston College), Natalia A. Kuzmina(Galveston College), Kai Huang(Galveston College), Philipp A. Ilinykh(Houston Methodist), Robert W. Cross(The University of Texas Medical Branch at Galveston), George K. Lewis(University of Maryland, Baltimore), Galit Alter(Ragon Institute of MGH, MIT and Harvard), Benjamin Ohiaeri(First Consultants Medical Center), Rachel S. Nargi(Vanderbilt University Medical Center), Hannah L. Turner(Scripps Research Institute), Tanwee Alkutkar(Scripps Research Institute), Chad E. Mire(United States Department of Agriculture), Adaora Okoli(First Consultants Medical Center), Robin Bombardi(Vanderbilt University Medical Center), Edgar Davidson(Integral Molecular (United States)), Thomas W. Geisbert(The University of Texas Medical Branch at Galveston), Aubrey L. Bryan(Integral Molecular (United States)), Chiara Orlandi(University of Maryland, Baltimore), Benjamin J. Doranz(Integral Molecular (United States)), Charles D. Murin(Scripps Research Institute), Andrew B. Ward(Scripps Research Institute), Erica Ollmann Saphire(La Jolla Institute for Immunology), Morris Ibeawuchi(First Consultants Medical Center), Robin Flinko(University of Maryland, Baltimore), Pilar X. Altman(Scripps Research Institute), Jacob C. Milligan(Scripps Research Institute), Sean Hui(Scripps Research Institute), Sheng Li(University of California San Diego), Megan E. Vodzak(Vanderbilt University Medical Center)
Cited by 0
Related Papers
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
|Proceedings of the National Academy of Sciences|2017|1.2k
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
|Cell Host & Microbe|2020|1.2k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors
|Nature Communications|2019|948